Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 185

Sort by

Sort Order Select

Journal Articles

Short survival with BCMA and GPRC5D dual antigen exposed relapsed myeloma- an international myeloma working group immunotherapy database analysis

Blood (2025) 146 (Supplement 1): 4598.

https://doi.org/10.1182/blood-2025-4598

Published: 2025

Journal Articles

Phase I/II study of mezigdomide and elranatamab for relapsed/refractory multiple myeloma patients (MELT-MM): Initial results from part 1

Ja Min Byun, Chang-Ki Min, Kihyun Kim, Dok Hyun Yoon, Sung-Hoon Jung, Wee-Joo Chng, Chandramouli Nagarajan, Youngil Koh

Blood (2025) 146 (Supplement 1): 5835.

https://doi.org/10.1182/blood-2025-5835

Published: 2025

Journal Articles

Super-enhancer-mediated regulation of CD38 inducibility in multiple myeloma via the MAF/TRIM47/RARα axis

Zhenfeng Dai, Yunlu Jia, Qiqi Shen, Haoguang Chen, Xinyuan Dai, Shengchun Jin, Enfan Zhang, Jianbiao Zhou, Gang Xiao, Wee-joo Chng, Zhen Cai

Blood (2025) 146 (Supplement 1): 2156.

https://doi.org/10.1182/blood-2025-2156

Published: 2025

Journal Articles

An open-label rollover study to assess the long-term safety of ixazomib

Sebastian Grosicki, Markus Hansson, Meletios Dimopoulos, Tadao Ishida, Vishal Kukreti, Dok Hyun Yoon, Wee-Joo Chng, Oliver Bechter, Xuejun Peng, Paul Richardson

Blood (2025) 146 (Supplement 1): 7547.

https://doi.org/10.1182/blood-2025-7547

Published: 2025

Journal Articles

Real world efficacy and safety of elranatamab, a BCMA bispecific antibody for patients with relapsed and refractory multiple myeloma: An international myeloma working group immunotherapy database analysis

Blood (2025) 146 (Supplement 1): 4588.

https://doi.org/10.1182/blood-2025-4588

Published: 2025

Journal Articles

Deciphering the dynamics of histone acetylation and chromatin remodeling in multiple myeloma: a tale beyond the tails

Sinan Xiong, Jianbiao Zhou, Wee-Joo Chng

Blood (2025) 146 (13): 1550–1560.

https://doi.org/10.1182/blood.2025028403

Published: 2025

Includes: Supplemental data

Journal Articles

The ADAR1-regulated cytoplasmic dsRNA-sensing pathway is a novel mechanism of lenalidomide resistance in multiple myeloma

Mun Yee Koh, Tae-Hoon Chung, Nicole Xin Ning Tang, Sabrina Hui Min Toh, Jianbiao Zhou, Tze King Tan, Leilei Chen, Wee Joo Chng, Phaik Ju Teoh

Blood (2025) 145 (11): 1164–1181.

https://doi.org/10.1182/blood.2024024429

Published: 2025

Includes: Supplemental data

Journal Articles

Characteristics and Outcomes of Acute Myeloid Leukemia in Ethnically Diverse Asians in Singapore

Natasha Fay Anthony, Yen-Lin Chee, Pak Ling Lui, Esther Chan, Michelle Poon, Lip Kun Tan, Jameelah Binte Sekh Mohamed, Liang Piu Koh, Melissa G OOI, Wee-Joo Chng, Wei-Ying Jen

Blood (2024) 144 (Supplement 1): 7899.

https://doi.org/10.1182/blood-2024-198845

Published: 2024

Journal Articles

Machine Learning Classification of Spatial Patterns of Malignant Cells Reveals Implications in Prognosis and Tumor Microenvironment Composition in Lymphoma

Blood (2024) 144 (Supplement 1): 3602.

https://doi.org/10.1182/blood-2024-209372

Published: 2024

Journal Articles

Proliferative CD8 T-Cells: A Novel Immune Microenvironmental Determinant of Outcomes in Multiple Myeloma with Translocation (4;14)

Blood (2024) 144 (Supplement 1): 1950.

https://doi.org/10.1182/blood-2024-198769

Published: 2024

Journal Articles

Outcomes of Elderly Patients with DLBCL and Utility of Geriatric Assessment Tools to Predict Chemotoxicity

Xinjie Jonathan Tang, Joanne Shu Xian Lee, Esther Hian Li Chan, Sanjay De Mel, Yen-Lin Chee, Wee-Joo Chng, Nicole-Ann Lim, Jason Yongsheng Chan, Soon Thye Lim, Shi Hui Clarice Choong, Melissa Gaik-Ming Ooi, Michelle Limei Poon

Blood (2024) 144 (Supplement 1): 3660.

https://doi.org/10.1182/blood-2024-208906

Published: 2024

Journal Articles

Real World Evidence of Outcomes of Patients Treated with Talquetamab in a Heavily Pretreated Population with Multiple Myeloma with High Exposure to Prior BCMA Therapies- a Report from the IMWG Consortium

Murali Janakiram, Carlyn Rose Tan, Rakesh Popat, Joaquín Martínez Lopez, Efstathios Kastritis, Chris Lau, Wee-Joo Chng, Prashant Kapoor, Hira Mian, Susan Bal, Ajay K. Nooka, Andre De Menezes Silva Corraes, Magdalena Corona, Arnab Chowdhury, Yi Lin, Thomas G Martin, Amrita Y Krishnan

Blood (2024) 144 (Supplement 1): 3368.

https://doi.org/10.1182/blood-2024-211167

Published: 2024

Journal Articles

Frequent Copy Gains of Viral LMP-1 Confers Radiosensitivity in Natural-Killer/T Cell Lymphoma

Jing Quan Lim, Dachuan Huang, Kelila Xin Ye Chai, Phyu The, Kerry May Huifen Lim, Wendy Lee, Liang Wei Wang, Nur Ayuni Muhammad Taib, Beng Hooi Phang, Wee-Joo Chng, Olaf Rötzschke, Jason Yongsheng Chan, Soon Thye Lim, Jin-Xin BEI, Siok-Bian Ng, Choon Kiat Ong

Blood (2024) 144 (Supplement 1): 2963.

https://doi.org/10.1182/blood-2024-192976

Published: 2024

Journal Articles

Evaluating the Comprehensive Geriatric Assessment Model As an Assessment Tool to Predict Chemotoxicity in Elderly Patients with Lymphoma

Xinjie Jonathan Tang, Joanne Shu Xian Lee, Esther Hian Li Chan, Sanjay De Mel, Yen-Lin Chee, Wee-Joo Chng, Michelle Limei Poon, Shi Hui Clarice Choong, Melissa Gaik-Ming Ooi

Blood (2024) 144 (Supplement 1): 388.

https://doi.org/10.1182/blood-2024-198867

Published: 2024

Journal Articles

Spatial-Resolved Transcriptomics Reveals Immune Landscape Variations in Primary Central Nervous System Lymphoma (PCNSL) and Diffuse Large B-Cell Lymphoma (DLBCL)

Min Liu, Liang Hong, Shruti Sridhar, Patrick Jaynes, Chartsiam Tipgomut, Limei Poon, Sanjay De Mel, Joanne Shu Xian Lee, Jayalakshmi, Siok-Bian Ng, Char Loo Tan, Wee-Joo Chng, Anand Devaprasath D. Jeyasekharan

Blood (2024) 144 (Supplement 1): 3004.

https://doi.org/10.1182/blood-2024-209497

Published: 2024

Journal Articles

The c-MAF/SLP76 Axis Modulates Immune Evasion and Drives Malignancy in Multiple Myeloma Via Epigenetic Reprogramming

Zhenfeng Dai, Yunlu Jia, Jianbiao Zhou, Wee-Joo Chng, Zhen Cai

Blood (2024) 144 (Supplement 1): 3277.

https://doi.org/10.1182/blood-2024-206958

Published: 2024

Journal Articles

Functional Characterization of Genes Residing in Chromosomal Regions with “High-Risk” Lesions in Multiple Myeloma

Phaik Ju Teoh, Ricardo De Matos Simoes, Tae-Hoon Chung, Torsten Steinbrunn, Lisa B Leypoldt, Olga Dashevsky, Francisca Vazquez, Wee-Joo Chng, Constantine S Mitsiades

Blood (2023) 142 (Supplement 1): 3293.

https://doi.org/10.1182/blood-2023-190050

Published: 2023

Journal Articles

Feasibility and Implementation of an out-of-Pocket Cost Calculator for Pre-Treatment Financial Counselling in Cancer Patients

Maggie Wong, Zhi Yao Chan, Mei Yin Quek, Alexis Koh, Constance Teo, Jinny Foo, Cheng Ean Chee, Andrea Wong, Samuel Ow, Joey Tay, Vivian Luah, Xiao Shi Saw, Yuet Peng Wong, Meng Tuck Lee, Jolene Lee, Chee-Yen Lin, Wei-Ying Jen, Wee-Joo Chng, Janelle Chua

Blood (2023) 142 (Supplement 1): 3728.

https://doi.org/10.1182/blood-2023-184753

Published: 2023

Journal Articles

A Clinical-Molecular Prognostic Scoring System for Myelodysplastic Syndrome in Asia - a Multicenter Study of the Asian Myeloid Working Group (AMWG)

Harinder Gill, Hsin An Hou, Paul Lee, Rita Yim, Xavier Cheng-Hong Tsai, Melissa Ooi, Tsz-Shing Hui, Radha Raghupathy, Lynn Chin, Lester Au, Vivian Li, Garret Man Kit Leung, Edmond Ma, Asif Javed, Ho-Wan Ip, Wee-Joo Chng, Wen-Chien Chou, Hwei-Fang Tien, Yok-Lam Kwong

Blood (2023) 142 (Supplement 1): 4598.

https://doi.org/10.1182/blood-2023-182750

Published: 2023

Journal Articles

Extracellular Vesicles Secreted from Daratumumab Resistant Cells Promote Resistance and Proliferation of Daratumumab Sensitive Cells, Possibly through the Transfer of miRNA Cargo

Irfan Azaman, Wee-Joo Chng, Nurulhuda Mustafa, Sanjay De Mel

Blood (2023) 142 (Supplement 1): 1443.

https://doi.org/10.1182/blood-2023-185134

Published: 2023

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Short survival with BCMA and GPRC5D dual antigen exposed relapsed myeloma- an international myeloma working group immunotherapy database analysis

Phase I/II study of mezigdomide and elranatamab for relapsed/refractory multiple myeloma patients (MELT-MM): Initial results from part 1

Super-enhancer-mediated regulation of CD38 inducibility in multiple myeloma via the MAF/TRIM47/RARα axis

An open-label rollover study to assess the long-term safety of ixazomib

Real world efficacy and safety of elranatamab, a BCMA bispecific antibody for patients with relapsed and refractory multiple myeloma: An international myeloma working group immunotherapy database analysis

Deciphering the dynamics of histone acetylation and chromatin remodeling in multiple myeloma: a tale beyond the tails

The ADAR1-regulated cytoplasmic dsRNA-sensing pathway is a novel mechanism of lenalidomide resistance in multiple myeloma

Characteristics and Outcomes of Acute Myeloid Leukemia in Ethnically Diverse Asians in Singapore

Machine Learning Classification of Spatial Patterns of Malignant Cells Reveals Implications in Prognosis and Tumor Microenvironment Composition in Lymphoma

Proliferative CD8 T-Cells: A Novel Immune Microenvironmental Determinant of Outcomes in Multiple Myeloma with Translocation (4;14)

Outcomes of Elderly Patients with DLBCL and Utility of Geriatric Assessment Tools to Predict Chemotoxicity

Real World Evidence of Outcomes of Patients Treated with Talquetamab in a Heavily Pretreated Population with Multiple Myeloma with High Exposure to Prior BCMA Therapies- a Report from the IMWG Consortium

Frequent Copy Gains of Viral LMP-1 Confers Radiosensitivity in Natural-Killer/T Cell Lymphoma

Evaluating the Comprehensive Geriatric Assessment Model As an Assessment Tool to Predict Chemotoxicity in Elderly Patients with Lymphoma

Spatial-Resolved Transcriptomics Reveals Immune Landscape Variations in Primary Central Nervous System Lymphoma (PCNSL) and Diffuse Large B-Cell Lymphoma (DLBCL)

The c-MAF/SLP76 Axis Modulates Immune Evasion and Drives Malignancy in Multiple Myeloma Via Epigenetic Reprogramming

Functional Characterization of Genes Residing in Chromosomal Regions with “High-Risk” Lesions in Multiple Myeloma

Feasibility and Implementation of an out-of-Pocket Cost Calculator for Pre-Treatment Financial Counselling in Cancer Patients

A Clinical-Molecular Prognostic Scoring System for Myelodysplastic Syndrome in Asia - a Multicenter Study of the Asian Myeloid Working Group (AMWG)

Extracellular Vesicles Secreted from Daratumumab Resistant Cells Promote Resistance and Proliferation of Daratumumab Sensitive Cells, Possibly through the Transfer of miRNA Cargo

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only